MoneyWorks4Me

Net sales declined -7.33%  to  Rs. 1158.57 million from Rs. 1250.24 millions.The Net Profit of the company slipped to Rs. 223.46 millions from Rs. 739.81 millions, a decline of -69.79% on QoQ basis.Operating profit for the quarter ended June 2026 decreased to 326.99 millions as compared to 843.78 millions of corresponding quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 1158.57 1250.24 -7.33 1158.57 1250.24 -7.33 4527.66 3514.11 28.84
Other Income 22.87 538.52 -95.75 22.87 538.52 -95.75 633.88 614.90 3.09
PBIDT 326.99 843.78 -61.25 326.99 843.78 -61.25 1738.22 1321.69 31.51
Interest 0.37 0.53 -30.19 0.37 0.53 -30.19 2.07 2.36 -12.29
PBDT 326.62 843.25 -61.27 326.62 843.25 -61.27 1697.57 1319.33 28.67
Depreciation 29.21 29.29 -0.27 29.21 29.29 -0.27 120.83 114.05 5.94
PBT 297.41 813.96 -63.46 297.41 813.96 -63.46 1576.74 1205.28 30.82
TAX 73.95 74.15 -0.27 73.95 74.15 -0.27 258.68 181.08 42.85
Deferred Tax 7.31 -0.26 -2911.54 7.31 -0.26 -2911.54 -12.01 12.22 -198.28
PAT 223.46 739.81 -69.79 223.46 739.81 -69.79 1318.06 1024.20 28.69
Equity 223.95 223.76 0.08 223.95 223.76 0.08 223.85 223.76 0.04
PBIDTM(%) 28.22 67.49 -58.18 28.22 67.49 -58.18 38.39 37.61 2.07

Advanced Enzyme Tech Share Price

305.95 2.70 (0.89%)
19-Aug-2026 11:05 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1892.05
Dr. Reddys Labs. 1180.60
Cipla 1425.15
Lupin 2215.80
Zydus Lifesciences 1114.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: